Please assess the completion status of the following clinical trial:

Trial Title: Soy Isoflavones and Breast Cancer Risk Reduction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy premenopausal women~* 30 to 42 years old~* normal mammograms~* regular menstrual cycles~Exclusion Criteria:~* abnormal mammograms~* first degree relatives with breast cancer~* pregnant or lactating~* peri- or post-menopause~* breast augmentation, reduction or lifting~* on oral contraceptive medications or exogenous hormones~* medically prescribed diets~* allergic reaction to soy products

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 42 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): soy isoflavones
- 2 (Type: PLACEBO_COMPARATOR): carbohydrates (maltodextrin)

Based on this trial design, predict the completion outcome and termination type (if applicable).